U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07545369) titled 'ULTRA-EVOLUT RCT: A Comparison of Latest-Generation TAVR Valves' on April 16.
Brief Summary: Title:
The ULTRA-EVOLUT Randomized Control Trial: A Head-to-Head Comparison of Latest-Generation Transcatheter Aortic Valves
Brief Summary:
The goal of this clinical trial is to compare the latest-generation balloon-expandable (SAPIEN 3 Ultra Resilia) versus self-expanding (Evolut FX) transcatheter aortic valves in patients with severe, symptomatic aortic stenosis who are undergoing transcatheter aortic valve implantation (TAVI).
The main questions it aims to answer are:
Does device success rate (defined by VARC-3 criteria) at 30 days ...